Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 7.14 B6.95 B7.45 B7.4 B7.32 B 29.11 B Research & development ————— — Operating income 5.75 B6.5 B6.12 B5.79 B6.66 B 25.07 B Non-Operating Income, Total 237 M-403 M4.53 B-1.52 B-1.26 B 1.35 B Interest expense, net of interest capitalized 1.66 B1.66 B1.7 B1.79 B1.81 B 6.96 B Non-Operating Income, excl. Interest Expenses -218 M-1.17 B-1.72 B-1.8 B-1.85 B -6.54 B Unusual income/expense 455 M767 M6.25 B278 M594 M 7.89 B Pretax income 5.99 B6.1 B10.65 B4.26 B5.4 B 26.41 B Equity in earnings 1.44 B485 M-20 M-10 M-41 M 414 M Taxes 1.3 B1.24 B976 M109 M1.18 B 3.5 B Non-controlling/minority interest 341 M361 M363 M368 M352 M 1.44 B After tax other income/expense ————— — Net income before discontinued operations 4.35 B4.5 B9.31 B3.79 B3.87 B 21.47 B Discontinued operations ————-38 M — Net income 4.35 B4.5 B9.31 B3.79 B3.83 B 21.43 B Dilution adjustment 4 M2 M3 M3 M3 M 11 M Preferred dividends -44 M36 M36 M36 M36 M 144 M Diluted net income available to common stockholders 4.4 B4.47 B9.28 B3.75 B3.8 B 21.3 B Basic earnings per share (Basic EPS) 0.610.621.290.520.54 2.97 Diluted earnings per share (Diluted EPS) 0.610.621.290.520.54 2.97 Average basic shares outstanding 7.21 B7.21 B7.16 B7.17 B7.02 B — Diluted shares outstanding 7.22 B7.22 B7.17 B7.18 B7.03 B — EBITDA 10.94 B11.75 B11.44 B10.92 B11.62 B 45.73 B EBIT 5.75 B6.5 B6.12 B5.79 B6.66 B 25.07 B Cost of revenue 6.34 B6.41 B6.35 B6.32 B6.26 B 25.35 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 5.19 B5.25 B5.32 B5.13 B4.97 B 20.66 B